Navigation Links
Diabetes drug supported by Mexican Diabetes Federation

VANCOUVER, June 21, 2007 /PRNewswire-FirstCall/ - Biotech Holdings reports that the Mexican Diabetes Federation has given Biotech's "Sucanon" diabetes drug its support in an overview of diabetic drugs published in the May-June 2007 issue of Diabetes Hoy, the Diabetic Federation's scientific and medical magazine for doctors and other health professionals.

The overview of diabetic drugs, written by Dr. Roberto Cepeda Gonzalez, Medical Director of the Specialized Center for Diabetes, in Mexico City, notes that Sucanon falls in a category of diabetic drugs known as "insulin sensitizers" for their action in making the body's cells more sensitive to circulating insulin. The review (see Endorsements at http://www.sucanonhealth.com/section.asp?pageid=4107) notes that the most widely used insulin sensitizers belong to a family of drugs known as thiazolidinediones or glitazones.

The glitazone drugs, the review notes, have a history of problems in contrast with Sucanon which, clinical studies have indicated, is very safe. The review notes that Sucanon does not have any of the hepatotoxicity or liver-damage risks of the glitazone drugs. The first glitazone, troglitazone was approved in 1998 but was withdrawn shortly thereafter. Two additional glitazones - rosiglitazone and pioglitazone - have recently been targeted with a "black box" warning by the U.S. FDA due to concerns related to cardiac risk when taking these drugs (see http://www.msnbc.msn.com/id/19090626/).

The review in Diabetes Hoy also notes that another widely used Type II Diabetes medication, metformin, presents risks for patients with compromised kidney function, frequently a symptom of Type II Diabetes.

Sucanon, which received regulatory approval in Mexico in 2004, is widely sold
'"/>




Page: 1 2 3

Related medicine technology :

1. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
2. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
3. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
4. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
5. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
8. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
9. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
10. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
11. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Diabetes drug supported Mexican Diabetes Federation
(Date:8/4/2015)... , Aug. 4, 2015 Among 1,000 ... medications, yet only half of consumers surveyed are aware ... have ever used use them, according to findings from ... a community service partnership focused on improving the health ... The online survey polled 1,000 men and women, ages ...
(Date:8/4/2015)... Wis. , Aug. 4, 2015  Ironshore ... agreement with Restore Health, a company specializing in ... a double-blind clinical trial, designed to evaluate the ... in development to treat Attention-deficit/hyperactivity disorder (ADHD). This ... Restore Health originally partnered with Ironshore ...
(Date:8/3/2015)... GLENWOOD, Ill. , Aug. 3, 2015  Landauer, ... personal and environmental radiation measurement and monitoring, outsourced medical ... announced it will release financial results for the fiscal ... August 10, 2015. The Company will ... August 11, 2015 at 9:00 a.m. Central Time (10:00 ...
Breaking Medicine Technology:New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2
... Maine, Oct. 21, 2011 IDEXX Laboratories, Inc. (NASDAQ: ... quarter of 2011 increased 12% to $301.0 million, from $269.6 ... as defined below, was 8%. Earnings per diluted share ("EPS") ... $0.66, compared to $0.59 for the same period in the ...
... Corporation (OTCBB: CDXC), the creator of pTeroPure®, today announced ... William Spengler to its Board of Directors. Mr. Honig ... board. Barry Honig is a specialist ... Chairman of InterCLICK (ICLK), a $150 million NASDAQ company.  ...
Cached Medicine Technology:IDEXX Laboratories Announces Third Quarter Results 2IDEXX Laboratories Announces Third Quarter Results 3IDEXX Laboratories Announces Third Quarter Results 4IDEXX Laboratories Announces Third Quarter Results 5IDEXX Laboratories Announces Third Quarter Results 6IDEXX Laboratories Announces Third Quarter Results 7IDEXX Laboratories Announces Third Quarter Results 8IDEXX Laboratories Announces Third Quarter Results 9IDEXX Laboratories Announces Third Quarter Results 10IDEXX Laboratories Announces Third Quarter Results 11IDEXX Laboratories Announces Third Quarter Results 12IDEXX Laboratories Announces Third Quarter Results 13IDEXX Laboratories Announces Third Quarter Results 14ChromaDex Announces Appointment of Barry Honig, Michael Brauser and William Spengler to Its Board of Directors 2ChromaDex Announces Appointment of Barry Honig, Michael Brauser and William Spengler to Its Board of Directors 3
(Date:8/4/2015)... ... , ... METTLER TOLEDO has announced an upcoming online symposium ... Pfizer, and Merck. This free online seminar will be held on September ... informed decisions with limited process understanding. Established methods have been developed to ...
(Date:8/4/2015)... ... 04, 2015 , ... Half of consumers are considering a ... increasingly influential in their choice of practitioner, according to new survey data from ... Cosmetic Dermatologic Procedures reflects overall consumer views on cosmetic medical treatments and ratings ...
(Date:8/4/2015)... ... ... The results of a three year clinical trial for the Argus II, a ... blindness, were published on June 23, 2015 in Ophthalmology , the journal of ... more commonly known as the “bionic eye,” is safe and effective for long-term treatment ...
(Date:8/4/2015)... ... August 04, 2015 , ... Rock Your Hair, http://www.rockyourhair.com ... Bash Tour. In addition, they have signed Lexi Noel, dubbed the Teen Beauty Queen ... print and overall branding opportunities for the company. , The Pop & Rock ...
(Date:8/4/2015)... , ... August 04, 2015 , ... More than 700 ... renewed their wedding vows on Friday, July 24th. Chaplains Shawn Kafader and Richard ... each other. Following the ceremony was a reception, with music by the Moonlight ...
Breaking Medicine News(10 mins):Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 4Health News:“Bionic Eye” Implant for the Blind Proved Safe and Effective at the End of a Three Year Clinical Trial 2Health News:Rock Your Hair Signs On As Title Sponsor For The HYPE! Projects Pop & Rock Beauty Bash Tour 2Health News:Couples Renew Vows at Friendship Village of Schaumburg 2
... one-fifth of primary care physicians in the US follow ... tests they recommend, according to Dr. Robin Yabroff from ... percent followed guidelines for some of the tests they ... guidelines for any of the screening tests they recommended. ...
... Randy Dotinga HealthDay Reporter , WEDNESDAY, Oct. 13 ... in poor countries could help HIV-infected mothers and their infants ... Currently, doctors lower the risk of transmission of mother-to-baby HIV ... and to babies right after. About half of the babies ...
... Ore According to new research conducted at Oregon ... power to combat fibromyalgia a medical disorder characterized ... in the November 10 online edition of the journal ... "Previous research suggests that the most successful treatment ...
... both medical progress and unmet needs in the ... Philadelphia will house the Network Coordinating Center for ... Research Network. Launched this year with ... federal government,s Maternal Child Health Bureau, the Network ...
... HealthDay Reporter , WEDNESDAY, Oct. 13 (HealthDay News) -- ... brain shrinkage in old age, which in turn helps stem ... reveals. "We have always been in search of the ... noted Kirk I. Erickson, an assistant professor of psychology at ...
... Gordon HealthDay Reporter , WEDNESDAY, Oct. 13 (HealthDay ... Virginia may have elevated blood pressure, according to new research ... "The real thrust of this research is trying to ... screen for hypertension [high blood pressure] in children. And, while ...
Cached Medicine News:Health News:Not all doctors follow cancer screening guidelines 2Health News:Studies Tout Alternative HIV Regimens for Women, Babies 2Health News:Studies Tout Alternative HIV Regimens for Women, Babies 3Health News:OHSU research suggests yoga can counteract fibromyalgia 2Health News:Children's Hospital coordinates new network for developmental disabilities 2Health News:Walking 6 to 9 Miles a Week May Help Save Memory 2Health News:Walking 6 to 9 Miles a Week May Help Save Memory 3Health News:Nearly 1 in 5 W.Va. 5th Graders May Have High Blood Pressure 2Health News:Nearly 1 in 5 W.Va. 5th Graders May Have High Blood Pressure 3
Inquire...
Inquire...
... new QIAvac 24 Plus vacuum manifold allows processing of ... tedious loading and unloading of spin columns into and ... Plus offers: Time savings ... DNA, PCR products, and RNA Convenience ...
... Vac Manifold is available to ... 30 minutes; the manifold is ... and a vacuum regulator with ... vacuum chamber, on/off switch, control ...
Medicine Products: